{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T11:31:01Z","timestamp":1774438261690,"version":"3.50.1"},"reference-count":33,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":340,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Hepatology"],"published-print":{"date-parts":[[2015,1]]},"abstract":"<jats:p>Pharmacological treatment of portal hypertension (PH) has been exclusively devoted to gastroesophageal varices\u2013related events at different frameworks, including prophylactic, emergency, or preventive therapy. The goals of treatment are to avoid the first bleeding episode, stop active bleeding, and prevent bleeding recurrence, respectively. The objective of preprimary prophylaxis (PPP) is to avoid variceal development, and therefore it necessarily deals with patients with cirrhosis at earlier stages of the disease. At these earlier stages, nonselective beta\u2010blockers (NSBBs) have been ineffective in preventing the development of varices and other complications of PH. Therefore, treatment should not rely on NSBB. It is possible that, at these earlier stages, etiological treatment of liver disease itself could prevent progression of PH. This review will focus mainly on early treatment of PH, because, if successful, it may translate into histological\u2010hemodynamic improvements, avoiding not only variceal development, but also other PH\u2010related complications, such as ascites and portosystemic encephalopathy. Moreover, the advent of new therapies may allow not only the prevention of the complications of PH, but also the chance of a substantial degree of regression in the cirrhotic process, with the possible prevention of hepatocellular carcinoma (HCC). (H<jats:sc>epatology<\/jats:sc> 2015;61:375\u2013381)<\/jats:p>","DOI":"10.1002\/hep.27249","type":"journal-article","created":{"date-parts":[[2014,6,9]],"date-time":"2014-06-09T16:16:41Z","timestamp":1402330601000},"page":"375-381","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":25,"title":["Prevention of portal hypertension: From variceal development to clinical decompensation"],"prefix":"10.1097","volume":"61","author":[{"given":"Julio D.","family":"Vorobioff","sequence":"first","affiliation":[{"name":"Hepatic Hemodynamic Lab,University of Rosario Medical School,Rosario,Argentina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto J.","family":"Groszmann","sequence":"additional","affiliation":[{"name":"Digestive Diseases Section,Yale University School of Medicine,New Haven,CT"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2014,9,26]]},"reference":[{"key":"hep27249-bib-0001-20241017","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1053\/j.gastro.2007.10.028","article-title":"How to prevent varices from bleeding: shades of grey\u2014the case for non\u2010selective \u03b2 blockers","volume":"133","year":"2007","journal-title":"Gastroenterology"},{"key":"hep27249-bib-0003-20241017","doi-asserted-by":"crossref","first-page":"S125","DOI":"10.1097\/01.mcg.0000155552.14396.3d","article-title":"Portal hypertension. From bedside to bench","volume":"39","year":"2005","journal-title":"J Clin Gastroenterol"},{"key":"hep27249-bib-0004-20241017","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.jhep.2010.03.021","article-title":"Hepatic endothelial dysfunction and abnormal angiogenesis: new targets in the treatment of portal hypertension","volume":"53","year":"2010","journal-title":"J Hepatol"},{"key":"hep27249-bib-0005-20241017","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1016\/j.jhep.2011.01.053","article-title":"Insulin resistance and liver microcirculation in a rat model of early NAFLD","volume":"55","year":"2011","journal-title":"J Hepatol"},{"key":"hep27249-bib-0006-20241017","first-page":"G980","article-title":"Mild increases in portal pressure upregulate vascular endothelial growth factor and endothelial nitric oxide synthase in the intestinal microcirculatory bed, leading to a hyperdynamic state","volume":"290","year":"2006","journal-title":"Am J Physiol"},{"key":"hep27249-bib-0008-20241017","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1056\/NEJMoa044456","article-title":"Beta\u2010blockers to prevent gastroesophageal varices in patients with cirrhosis","volume":"353","year":"2005","journal-title":"N Engl J Med"},{"key":"hep27249-bib-0009-20241017","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1136\/gut.27.10.1204","article-title":"Influence of the degree of liver failure on systemic and splanchnic hemodynamics and on response to propranolol in patients with cirrhosis","volume":"27","year":"1986","journal-title":"Gut"},{"key":"hep27249-bib-0012-20241017","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1097\/00042737-199907000-00011","article-title":"Lack of effect of propranolol in the prevention of large oesophageal varices in patients with cirrhosis: a randomized trial","volume":"11","year":"1999","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"hep27249-bib-0013-20241017","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1053\/gast.1996.v111.pm8780575","article-title":"Prognostic value of hepatic venous pressure measurement in alcoholic cirrhosis: a ten year prospective study","volume":"111","year":"1996","journal-title":"Gastroenterology"},{"key":"hep27249-bib-0014-20241017","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1053\/j.gastro.2004.05.004","article-title":"A placebo\u2010controlled clinical trial of nadolol in the prophylaxis of growth of small esophageal varices in cirrhosis","volume":"127","year":"2004","journal-title":"Gastroenterology"},{"issue":"Suppl. 1","key":"hep27249-bib-0016-20241017","first-page":"1020 A","article-title":"Lack of effect of non\u2010selective beta\u2010blockers on the hepatic venous pressure gradient (HVPG) in patients with mild portal hypertension: a tail of two studies [Abstract]","volume":"52","year":"2010","journal-title":"Hepatology"},{"key":"hep27249-bib-0017-20241017","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1053\/j.gastro.2007.05.024","article-title":"Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis","volume":"133","year":"2007","journal-title":"Gastroenterology"},{"key":"hep27249-bib-0018-20241017","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1111\/j.1478-3231.2012.02830.x","article-title":"Prognostic indicators of survival in patients with compensated and decompensated cirrhosis","volume":"32","year":"2012","journal-title":"Liver Int"},{"key":"hep27249-bib-0019-20241017","doi-asserted-by":"crossref","first-page":"487","DOI":"10.3109\/00365521.2012.711848","article-title":"Prognostic value of hepatic venous pressure gradient in patients with compensated chronic hepatitis C\u2010related cirrhosis","volume":"48","year":"2013","journal-title":"Scand J Gastroent"},{"key":"hep27249-bib-0020-20241017","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.jhep.2009.01.014","article-title":"Hepatic venous pressure gradient predicts development of hepatocellular carcinoma independently of severity of cirrhosis","volume":"50","year":"2009","journal-title":"J Hepatol"},{"key":"hep27249-bib-0021-20241017","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.cgh.2011.04.013","article-title":"Patients with clinically significant portal hypertension caused by hepatitis C virus cirrhosis respond poorly to antiviral therapy","volume":"9","year":"2011","journal-title":"Clin Gastroenterol Hepatol"},{"key":"hep27249-bib-0023-20241017","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1002\/hep.23528","article-title":"Sustained virologic response prevents the development of esophageal varices in compensated, Child\u2010Pugh class A hepatitis C virus\u2013induced cirrhosis. A 12\u2010year prospective follow\u2010up study","volume":"51","year":"2010","journal-title":"Hepatology"},{"key":"hep27249-bib-0024-20241017","first-page":"1883","article-title":"New therapeutic paradigm for patients with cirrhosis","volume":"56","year":"2012","journal-title":"Hepatology"},{"key":"hep27249-bib-0025-20241017","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1002\/hep.25762","article-title":"The diagnosis and management of non\u2010alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association","volume":"55","year":"2012","journal-title":"Hepatology"},{"key":"hep27249-bib-0026-20241017","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1002\/hep.23258","article-title":"Alcoholic Liver Disease","volume":"51","year":"2010","journal-title":"Hepatology"},{"key":"hep27249-bib-0027-20241017","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1002\/hep.22759","article-title":"AASLD Practice Guidelines. Diagnosis, management, and treatment of hepatitis C: an update","volume":"49","year":"2009","journal-title":"Hepatology"},{"key":"hep27249-bib-0028-20241017","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.jhep.2013.03.030","article-title":"NS5A inhibitors in the treatment of hepatitis C","volume":"59","year":"2013","journal-title":"J Hepatol"},{"key":"hep27249-bib-0030-20241017","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1002\/hep.21513","article-title":"AASLD Practice Guidelines. Chronic hepatitis B","volume":"45","year":"2007","journal-title":"Hepatology"},{"key":"hep27249-bib-0031-20241017","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.jhep.2004.01.009","article-title":"Decreased fibrosis during corticosteroid therapy of autoimmune hepatitis","volume":"40","year":"2004","journal-title":"J Hepatol"},{"key":"hep27249-bib-0032-20241017","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1053\/j.gastro.2008.07.019","article-title":"Portal hypertension and primary biliary cirrhosis: effect of long\u2010term ursodeoxycholic acid treatment","volume":"135","year":"2008","journal-title":"Gastroenterology"},{"key":"hep27249-bib-0033-20241017","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1002\/hep.21260","article-title":"Reversibility of hepatic fibrosis in treated genetic hemochromatosis: a study of 36 cases","volume":"44","year":"2006","journal-title":"Hepatology"},{"key":"hep27249-bib-0034-20241017","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.cld.2013.12.005","article-title":"Primary prophylaxis of variceal bleeding","volume":"18","year":"2014","journal-title":"Clin Liver Dis"},{"key":"hep27249-bib-0035-20241017","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.jhep.2013.09.016","article-title":"The changing role of beta\u2010blocker therapy in patients with cirrhosis","volume":"60","year":"2014","journal-title":"J Hepatol"},{"issue":"Suppl 1","key":"hep27249-bib-0036-20241017","first-page":"S385","article-title":"Bleeding\u2010unrelated mortality is not increased in patients with cirrhosis and ascites on treatment with \u03b2\u2010blockers: a meta\u2010analysis","volume":"60","year":"2014","journal-title":"J Hepatol"},{"key":"hep27249-bib-0037-20241017","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1002\/hep.21731","article-title":"Transient elastography for diagnosis of portal hypertension in liver cirrhosis: is there still a role for hepatic venous pressure gradient measurement?","volume":"45","year":"2007","journal-title":"Hepatology"},{"key":"hep27249-bib-0038-20241017","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1056\/NEJM198810133191505","article-title":"Prediction of the first variceal hemorrhage in patients with cirrhosis of the liver and esophageal varices","volume":"319","year":"1988","journal-title":"N Engl J Med"},{"key":"hep27249-bib-0039-20241017","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1056\/NEJMoa0910102","article-title":"Early use of TIPS in patients with cirrhosis and variceal bleeding","volume":"362","year":"2010","journal-title":"N Engl J Med"},{"key":"hep27249-bib-0040-20241017","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.jhep.2012.10.023","article-title":"The natural history of compensated HCV\u2010related cirrhosis: a prospective, long\u2010term study","volume":"58","year":"2013","journal-title":"J Hepatol"}],"container-title":["Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fhep.27249","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/01515467-201501000-00043","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,18]],"date-time":"2024-10-18T00:56:15Z","timestamp":1729212975000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01515467-201501000-00043"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9,26]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.1002\/hep.27249","relation":{},"ISSN":["0270-9139","1527-3350"],"issn-type":[{"value":"0270-9139","type":"print"},{"value":"1527-3350","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,9,26]]},"assertion":[{"value":"2014-01-23","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2014-05-31","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}